Comparator: placebo comparator

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC, University of Brasilia

Conditions

AsthmaType 2 Diabetes

Phase 1

A Multiple-Dose Study of MK-1006 (MK-1006-004)(TERMINATED)

TerminatedNCT00758680

Merck Sharp & Dohme LLCType 2 Diabetes

Start: 2008-08-31End: 2010-03-31Updated: 2016-02-05

Phase 4

Study to Evaluate the Inflammatory Cells Activity in Patients With Persistent Asthma Treated With Montelukast (0476-403)(COMPLETED)

CompletedNCT00770900

University of BrasiliaAsthma

Start: 2008-09-30End: 2009-12-31Updated: 2010-12-20